Correlation Between Pliant Therapeutics and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Crispr Therapeutics AG, you can compare the effects of market volatilities on Pliant Therapeutics and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Crispr Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Crispr Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pliant and Crispr is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Crispr Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Crispr Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.07 times less risky than Crispr Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Crispr Therapeutics AG is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 5,076 in Crispr Therapeutics AG on September 2, 2024 and sell it today you would earn a total of 41.00 from holding Crispr Therapeutics AG or generate 0.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Pliant Therapeutics |
| Crispr Therapeutics |
Pliant Therapeutics and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Crispr Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |